EEOFX | PAMCX | EEOFX / PAMCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 24 years | - |
Gain YTD | 0.000 | 5.599 | - |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 41.6M | 29.8B | 0% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 0.23 | 5.80 | 4% |
Returns for 3 years | -36.31 | -20.28 | 179% |
Returns for 5 years | 26.07 | 8.44 | 309% |
Returns for 10 years | N/A | 30.71 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SEMGX | 18.11 | 0.07 | +0.39% |
DWS Emerging Markets Equity S | |||
FFARX | 15.46 | N/A | N/A |
Franklin Global Allocation R | |||
TVRVX | 23.27 | N/A | N/A |
Third Avenue Real Estate Value Investor | |||
TRIPX | 23.94 | N/A | N/A |
Nuveen International Eq Idx Premier | |||
FTDZX | 153.28 | -1.05 | -0.68% |
Franklin Biotechnology Discovery Adv |